It's a bit of a perfect storm. Our regulatory fees are high relative to our market size. Particularly for food-producing animals, the fees are much higher, because we're requiring a lot more clinical data, a lot more Canadian-specific studies.
To your point, a lot of these animals are moving back and forth across the border in the production cycle. To say that we have requirements just for Canadian cattle or Canadian dairy overlooks the fact that the animals—including American ones—move back and forth across the border, so it becomes difficult to justify why we have a lot of very Canadian-specific requirements, particularly when we're dealing with products that are licensed and used extensively in the United States.
If you look at the American compendium of what American veterinarians and producers have available to them in terms of the choice of products, their product selection is far beyond what we have available in Canada. Over the last five to seven years, we've seen a loss of products rather than an increase. The reliance order is a good step to start remedying that, but I think there needs to be a comprehensive approach, looking at all the factors that contribute to that.